Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUMMACTA: Tocilizumab SC vs IV in Rheumatoid Arthritis
NCT01194414Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2010
- Primary completion
- Jan 2012
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 26
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Sep 2010; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01194414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194414.